HISTONDEMETHYLASE-INHIBITOREN
European patent · EP2970211 · Deleted
Register entry
- Publication number
- EP2970211
- Application number
- EP14768099
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 12, 2014
- Published
- Jan 20, 2016
- Granted
- Jul 26, 2017
- Deleted
- Oct 23, 2024
- Reason
- Annual fee unpaid
- IPC classes
- C07D 471/04 (2006.01)A61K 31/519 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 201361791406 P 15.03.2013
- PCT application
- PCT/US2014/024998 12.03.2014
- PCT publication
- WO2014/151106 25.09.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 23, 2024
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 23.10.2024
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 23.10.2024
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- Sep 13, 2019
Transferred
- Owner
- Quanticel Pharmaceuticals Inc, 9393 Towne Centre Drive, Suite 110, San Diego, CA 92121, USA → Celgene Quanticel Research, Inc., 9393 Towne Centre Drive, San Diego, CA 92121, USA
Published in Swissreg on 13.09.2019
- Oct 3, 2017
Agent entered
- Representative
- MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex
Published in Swissreg on 03.10.2017
- Jul 26, 2017
Granted
Published in Swissreg on 26.07.2017
Parties
Inventor
KANOUNI, Toufike
San Diego, CA 92121, US
STAFFORD, Jeffrey Alan
San Diego, CA 92130, US
VEAL, James Marvin
Apex, NC 27502, US
WALLACE, Michael Brennan
San Diego, CA 92117, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.